Clinical analysis of 117 cases with synchronous multiple primary esophageal squamous cell carcinomas
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: We aimed to study the clinical characteristics, treatment modality, and the prognosis of synchronous multiple primary esophageal squamous cell carcinomas (SMPESCC). Methods: A total of 117 SMPESCC cases were evaluated retrospectively from 2010 to 2015. Results: The most common locations of SMPESCC were mid- and lower thoracic segments (n = 208, 84.9%). The 1-, 2-, and 3-year overall survival rates were 53.8%, 30.8%, and 15.4%, respectively; the median survival time (MST) was 12.5 months. With definitive radiotherapy and surgery, respectively, the MST of stage I/II patients were 34.2 and 26.7 months, of stage III patients were 8.3 and 13.2 months (p = 0.163), and of stage IV patients were and 8 and 12.6 months (p = 0.379). Clinical stage, family history of cancer, and Karnofsky performance status were independent prognostic factors for the whole cohort by Cox multivariate regression analysis (hazard ratio [HR] = 0.859, p < 0.001; HR = 0.579, p = 0.032; and HR = 0.586, p = 0.013). Conclusions: Although the prognosis of SMPESCC is poor, stage I/II patients can achieve long-term survival with aggressive treatment, especially those with a Karnofsky performance score 90 or higher and who have no family history of cancer. Definitive radiotherapy could achieve a similar survival rate to definitive surgery at different clinical stages.
Abstract
Background/Aims: We aimed to study the clinical characteristics, treatment modality, and the prognosis of synchronous multiple primary esophageal squamous cell carcinomas (SMPESCC). Methods: A total of 117 SMPESCC cases were evaluated retrospectively from 2010 to 2015. Results: The most common locations of SMPESCC were mid- and lower thoracic segments (n = 208, 84.9%). The 1-, 2-, and 3-year overall survival rates were 53.8%, 30.8%, and 15.4%, respectively; the median survival time (MST) was 12.5 months. With definitive radiotherapy and surgery, respectively, the MST of stage I/II patients were 34.2 and 26.7 months, of stage III patients were 8.3 and 13.2 months (p = 0.163), and of stage IV patients were and 8 and 12.6 months (p = 0.379). Clinical stage, family history of cancer, and Karnofsky performance status were independent prognostic factors for the whole cohort by Cox multivariate regression analysis (hazard ratio [HR] = 0.859, p < 0.001; HR = 0.579, p = 0.032; and HR = 0.586, p = 0.013). Conclusions: Although the prognosis of SMPESCC is poor, stage I/II patients can achieve long-term survival with aggressive treatment, especially those with a Karnofsky performance score 90 or higher and who have no family history of cancer. Definitive radiotherapy could achieve a similar survival rate to definitive surgery at different clinical stages.
참고문헌 (24)
- Cahan WG, "Separate primary carcinomas of the esophagus and head and neck region in the same patient", Cancer, 37, pp.85~89 (1976)
- Warren S, "Multiple primary malignant tumors : a survey of the literature and statistical study", Am J Cancer, 16, pp.1358~1414 (1932)
- Nowell PC, "The clonal evolution of tumor cell populations", Science, 194, pp.23~28 (1976)
- Strong MS, "Field cancerization in the aerodigestive tract : its etiology, manifestation, and significance", J Otolaryngol, 13, pp.1~6 (1984)
- Kuwabara T, "Genetic pathways of multiple esophageal squamous cell carcinomas", Oncol Rep, 25, pp.453~459 (2011)
- Torre LA, "Global cancer statistics, 2012", CA Cancer J Clin, 65, pp.87~108 (2015)
- Lin Y, "Epidemiology of esophageal cancer in Japan and China", J Epidemiol, 23, pp.233~242 (2013)
- Jin Seo Lee, "Synchronous second primary cancers in patients with squamous esophageal cancer: clinical features and survival outcome", The Korean Journal of Internal Medicine, 31(2), pp.253~259 (2016), 대한내과학회[DOI]
- Wang R, "Upper gastrointestinal endoscopy detection of synchronous multiple primary cancers in esophagus and stomach : single center experience from china", Gastroenterol Res Pract, 2012, pp.432367~ (2012)
- Xiao ZF, "Radiotherapy of multi-focal esophageal carcinoma", Chin J Radiat Oncol, 4, pp.222~224 (1989)
- Chen W, "The incidence and mortality of major cancers in China, 2012", Chin J Cancer, 35, pp.73~ (2016)
- Li M, "Characteristics and prognostic factors of synchronous multiple primary esophageal carcinoma : a report of 52 cases", Thorac Cancer, 5, pp.25~30 (2014)
- Xu H, "The clinical significance of 18F-FDG-PET", CT in early detection of second primary malignancy in cancer patients, 2010, pp.136, 1125~1134
- fluoro-D-glucose positron emission tomography(FDG-PET)to detect early synchronous primary cancers in patients with untreated head and neck squamous cell cancer, "Ann Nucl Med", 2013, 880~885
- Hori K, "Lugol-voiding lesions are an important risk factor for a second primary squamous cell carcinoma in patients with esosphageal cancer or head and neck cancer", Am J Gastroenterol, 106, pp.858~866 (2011)
- Coia LR, "Outcome of patients receiving radiation for cancer of the esophagus : results of the 1992-1994 patterns of care study", J Clin Oncol, 18, pp.455~462 (2000)
- Gao Y, "Family history of cancer and risk for esophageal and gastric cancer in Shanxi, China", BMC Cancer, 9, pp.269~ (2009)
- Burmeister BH, "Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus : a randomised controlled phase III trial", Lancet Oncol, 6, pp.659~668 (2005)
- Bedenne L, "Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus : FFCD 9102", J Clin Oncol, 25, pp.1160~1168 (2007)
- Wu PC, "The role of surgery in the management of oesophageal cancer", Lancet Oncol, 4, pp.481~488 (2003)
- Shinoto M, "Clinical results of definitive chemoradiotherapy for patients with synchronous head and neck squamous cell carcinoma and esophageal cancer", Am J Clin Oncol, 34, pp.362~366 (2011)
- Shirai K, "Prognosis was not deteriorated by multiple primary cancers in esophageal cancer patients treated by radiotherapy", J Radiat Res, 54, pp.706~711 (2013)
- Smith TJ, "Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group", Int J Radiat Oncol Biol Phys, 42, pp.269~276 (1998)
- Bosset JF, "Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus", N Engl J Med, 337, pp.161~167 (1997)